ALKS Alkermes PLC

Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.

$18.20  -0.45 (-2.39%)
As of 03/04/2021 15:59:43 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
Ireland
02/02/2001
159,237,889
1,383,251
$2,968,194,251
0.00%
SEC Edgar Online
10-Q
10-K
G01767105
IE00B56GVS15
B3P6D26

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-26.77
2.78
2.86
-10.39%
-10.67%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy